semaglutide pills versus injections Tablets vs Injection: Which Is Best? Wegovy® Pill vs. Injection: The

Whether youve been on a weight loss journey, experienced multiple pregnancies, or are simply dealing with the natural effects of aging, you deserve to feel comfortable in your own skin

These are common peptide-handling practices and should not be interpreted as manufacturer instructions

Key Takeaways Gastrointestinal events are the most common adverse effects: Nausea, diarrhea, and vomiting were reported in 4067% of participants at higher doses in published Phase 2 trial data Adverse events are dose-dependent: Higher retatrutide doses consistently produced higher rates of GI events across all published trials Most adverse events were mild to moderate: The Phase 2 trial reported the majority of events as Grade 1-2 in severity Discontinuation rates ranged from 610%: Published data shows dropout rates due to adverse events were comparable to other GLP-1 class compounds Retatrutide is not FDA-approved: All safety data comes from investigational clinical trials it remains a research compound What Clinical Trials Tell Us About Retatrutide Adverse Events Retatrutide (LY3437943) is an investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously

Specifically, research by Svensson et al